Cartesian Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.6M | 649k | 10.22 |
| 2025-06-30 | $6.8M | 654k | 10.39 |
| 2025-03-31 | $8.9M | 673k | 13.18 |
| 2024-12-31 | $12M | 659k | 17.91 |
| 2024-09-30 | $6.8M | 424k | 16.12 |